Ketorolac 0.45% Ophthalmic Solution

@article{McCormack2011Ketorolac0O,
  title={Ketorolac 0.45% Ophthalmic Solution},
  author={P. L. McCormack},
  journal={Drugs & Aging},
  year={2011},
  volume={28},
  pages={583-589}
}
  • P. L. McCormack
  • Published 2011
  • Medicine
  • Drugs & Aging
  • Ketorolac 0.45% ophthalmic solution is a topical NSAID indicated in the US for the treatment of ocular pain and inflammation following cataract surgery.In animal studies, the ocular relative bioavailability of single-dose topical ketorolac 0.45% ophthalmic solution was 2- to 3-fold higher than that of ketorolac 0.4% ophthalmic solution.In two identically designed, randomized, double-masked, multicentre trials in adult patients undergoing cataract extraction, the proportions of patients with a… CONTINUE READING
    Comparing the Efficacy of Ophthalmic NSAIDs in Common Indications
    • 29
    Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
    • 52
    • PDF
    Intranasal Ketorolac
    • 4

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 16 REFERENCES